date:May 29, 2012
The firm, which is expanding its facility in Sherbrooke, Qubec, to meet growing demand, said nutraceutical sales rose 31% to $5.36m in the three months to February 29, while net profits in the division were $1.38m, compared with a net loss of $985,000 for the same period last year.
For the full year to February 29, nutraceuticals revenues were up 15% to $19.11m, while net income rose sharply from $1.01m to $2.38m.
Consolidated revenues - which include figures from the Acasti Pharma and NeuroBi